We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Asana
ASAN
$2.13B
| $4.39M | ﹤0.01% |
319,197
-162,542
| -34% | -$2.95M |
|
1952
BioXcel Therapeutics
BTAI
$27.8M
| $4.39M | ﹤0.01% |
12,775
-827
| -6% | -$200K |
|
1953
Hain Celestial
HAIN
$53.7M
| $4.39M | ﹤0.01% |
271,234
-18,292
| -6% | -$326K |
|
1954
Enovix
ENVX
$1.03B
| $4.38M | ﹤0.01% |
402,770
-705,629
| -64% | -$8.68M |
|
1955
Herbalife
HLF
$1.29B
| $4.38M | ﹤0.01% |
294,538
-47,346
| -14% | -$824K |
|
1956
AngioDynamics
ANGO
$649M
| $4.37M | ﹤0.01% |
317,475
+55,371
| +21% | +$770K |
|
|
ONT
1957
Onterris Inc
ONT
$580M
| $4.36M | ﹤0.01% |
98,154
-2,828
| -3% | -$120K |
|
1958
Independent Bank Corp
IBCP
$844M
| $4.35M | ﹤0.01% |
181,915
-11,033
| -6% | -$252K |
|
|
PRVB
1959
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $4.35M | ﹤0.01% |
411,306
+29,409
| +8% | +$237K |
|
|
FNA
1960
DELISTED
Paragon 28, Inc.
FNA
| $4.33M | ﹤0.01% |
226,713
+65,267
| +40% | +$1.23M |
|
|
ACCD
1961
DELISTED
Accolade Inc
ACCD
| $4.31M | ﹤0.01% |
553,565
+240,314
| +77% | +$2.29M |
|
1962
First Bancorp
FBNC
$2.68B
| $4.31M | ﹤0.01% |
100,632
-17,538
| -15% | -$768K |
|
|
PFC
1963
DELISTED
Premier Financial Corp. Common Stock
PFC
| $4.3M | ﹤0.01% |
159,490
-16,309
| -9% | -$456K |
|
|
STEL
1964
DELISTED
Stellar Bancorp
STEL
| $4.26M | ﹤0.01% |
+190,760
| New | +$5.91M |
|
|
WOW
1965
DELISTED
WideOpenWest
WOW
| $4.26M | ﹤0.01% |
467,527
-125,943
| -21% | -$1.43M |
|
1966
iShares MSCI South Korea ETF
EWY
$25.7B
| $4.24M | ﹤0.01% |
75,112
+24,480
| +48% | +$1.34M |
|
1967
Acushnet Holdings
GOLF
$5.45B
| $4.23M | ﹤0.01% |
99,672
-14,163
| -12% | -$638K |
|
1968
Vanda Pharmaceuticals
VNDA
$302M
| $4.23M | ﹤0.01% |
572,615
-506,276
| -47% | -$4.93M |
|
1969
Weis Markets
WMK
$1.86B
| $4.22M | ﹤0.01% |
51,257
-8,260
| -14% | -$697K |
|
1970
Urban Outfitters
URBN
$6.59B
| $4.21M | ﹤0.01% |
176,553
-77,610
| -31% | -$1.93M |
|
1971
Central Garden & Pet Co Class A
CENTA
$2.44B
| $4.21M | ﹤0.01% |
146,989
-31,372
| -18% | -$943K |
|
1972
XPeng
XPEV
$11.6B
| $4.21M | ﹤0.01% |
423,558
-699,973
| -62% | -$6.31M |
|
1973
Titan International
TWI
$475M
| $4.21M | ﹤0.01% |
274,537
+43,309
| +19% | +$618K |
|
1974
DocGo
DCGO
$62.6M
| $4.2M | ﹤0.01% |
594,476
-249,595
| -30% | -$2.09M |
|
|
EVOP
1975
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $4.2M | ﹤0.01% |
124,003
-24,793
| -17% | -$833K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.